<DOC>
	<DOCNO>NCT01049880</DOCNO>
	<brief_summary>This study design determine maximum tolerate dose vitamin C give standard chemotherapy people metastatic pancreatic cancer .</brief_summary>
	<brief_title>A Research Trial High Dose Vitamin C Chemotherapy Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>This phase I , dose-escalating study ascorbic acid ( vitamin C ) design determine maximum tolerate dose vitamin C , well tolerate , dose require obtain desired ascorbic acid plasma concentration . Because phase I study , prospective subject advanced disease ( i.e. , metastasis ) fail curative therapy ( , unable receive curative therapy due comorbidities stage disease ) .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Normal G6PD status Histologically cytologically diagnose pancreatic adenocarcinoma . Disease extent document CT scan ( radiologically measurable disease require ) Ambulatory patient without evidence spinal cord compression No prior chemotherapy metastatic disease Failed curative therapy patient ineligible definitive curative therapy Completed adjuvant therapy least 4 week prior recover any/all toxicity relate treatment . If posttherapy , must disease progression since treatment If treat prior radiation therapy , disease must outside radiation field No currently active second malignancy unless nonmelanoma skin cancer Women must nonpregnant nonlactating ECOG performance 0 , 1 , 2 Granulocytes least 1,500 / ul Platelets least 100,000 / ul Creatinine le 1.5 mg/dL clearance least 60 mL / min Total bilirubin less 2 time upper limit normal AST ALT less 3 time upper limit normal liver metastasis present . If liver metastasis present , AST ALT less 5 time upper limit normal PT INR le 1.5 ( unless patient full dose warfarin ) Patient must least 18 year age Patient must able understand consent process , research study , able sign consent document A psychiatric disorder history examination would prevent completion study ECOG performance 3 4 Comorbid condition affect survival : end stage congestive heart failure , unstable angina , myocardial infarction ( within past 6 week ) , uncontrolled blood sugar great 300 mg/dL , know chronic active hepatitis cirrhosis . Consumption excess alcohol ( 4 drink per day ) use illicit drug Continued sse overthecounter antioxidant ( supplement like vitamin C grape seed )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Ascorbic Acid</keyword>
	<keyword>Gemcitabine</keyword>
</DOC>